BWV News and Press, Blue Water Vaccines Inc. From 03/22/22

Blue Water Vaccines has exclusive, global licensing rights to Cincinnati Children’s Hospital Medical Center’s novel virus-like particle (VLP) vaccine platform. The data supports BWV’s ongoing development of a transformational universal influenza vaccine, as well...

Blue Water Vaccines (NASDAQ:BWV) shares plunged 50% on Tuesday, hitting a 52-week low, but were still trading 278% above their initial public offering price. Shares of the influenza vaccine developer last changed hands at $34, down 50% from the prior session, at approximately 12:45 p.m. ET. T...

Emerging Markets are outperforming the rest of the world, due in large part to windfall profits in the commodities-exporting countries of South America and the Middle East. If you want to follow the money, this is a good place to start. Money has been flowing out of tech, consumer dis...

CINCINNATI, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing vaccines, today announced the closing of its initial public offering of 2,222,222 shares of its common stock at a public offering ...

Blue Water Vaccines (NASDAQ:BWV) shares tumbled 30% Wednesday as the stock continued to decline after soaring over 500% during its market debut last week. The stock opened at $47.39, falling to $32.55 before shooting up to $51.80 and then sliding into the lower $40 range. Shares of the vaccin...

Larger companies have the advantage of scale, pricing power, greater ability to pass on higher costs to consumers, and stronger negotiating power with suppliers to name a few. Net profit will be an area looked at closely given the potential for multiple Fed rate hikes which will incre...

Newly public Blue Water Vaccines (NASDAQ:BWV) stock was halted several times Tuesday as shares soared 58% early trading before tumbling midday. Shares of the vaccine maker opened at $67.50 after closing at $57.40 on Friday. The stock soared 58% to hit a session high of $90.90 Tuesday morning ...

CINCINNATI, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines, Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing vaccines, today announced the pricing of its initial public offering of 2,222,222 shares of its common stock at a public offering...